# DESCRIPTION

## STATEMENT OF FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT

- acknowledge government support

## TECHNICAL FIELD

- define technical field

## BACKGROUND OF INVENTION

- introduce nanoparticles
- discuss toxicity of metallic nanoparticles
- discuss cerium oxide nanoparticles
- discuss complexities of testing nanoparticles
- discuss uptake mechanisms of nanoparticles

## BRIEF SUMMARY OF INVENTION

- introduce redox-active nanoparticles
- describe immunomodulatory applications
- describe cerium oxide and titanium dioxide nanoparticles
- describe disparate redox chemistries
- describe modulation of immune response
- describe modulation of antigen presenting cells
- describe modulation of CD4+ T helper cells
- describe modulation of CD8+ T helper cells
- describe modulation of TH1-type immune response
- describe modulation of TH2-type immune response
- describe induction of TH2 T cell response
- describe induction of dendritic cell cytokine production
- describe induction of TH2 T cell cytokine production
- describe induction of TReg T cell response
- describe induction of TH1 T cell response
- describe induction of TH1 T cell cytokine production
- describe induction of dendritic cell cytokine production
- describe treatment of autoimmune disease
- describe modulation of immune system during cancer treatment
- describe treatment of allergic inflammation

## DETAILED DESCRIPTION OF THE INVENTION

### I. Definitions

- establish technical terms
- define specific terms

### II. The Present Invention

- introduce TH1 and TH2 cells
- describe TH1 cell characteristics
- describe TH2 cell characteristics
- explain TH1 and TH2 cell antagonism
- discuss TH1 and TH2 cytokine balance
- describe autoimmune disease implications
- discuss TH1 and TH2 cell development control
- introduce regulatory T cells
- discuss modulating TH1/TH2 balance strategies
- introduce redox-active nanoparticles
- describe cerium oxide nanoparticle properties
- describe titanium dioxide nanoparticle properties
- discuss nanoparticle-induced immune responses
- describe DC and T cell response modulation
- discuss TH1 and TH2 cytokine production
- describe TReg response promotion
- discuss nanoparticle surface reactivity influence
- describe nanoparticle size influence on immune responses
- discuss CeO2 NP therapeutic applications
- discuss TiO2 NP therapeutic applications
- describe nanoparticle characteristics
- specify CeO2 NP diameter ranges
- specify TiO2 NP diameter ranges
- introduce pharmaceutical formulations
- describe carrier options
- discuss formulation administration methods
- describe encapsulated nanoparticle formulations
- discuss means for administration
- discuss amounts for administration
- define concentration of nanoparticles
- specify suitable ranges of concentration
- list particular concentrations
- describe volume of pharmaceutical formulation
- specify suitable ranges of volume
- list particular volumes
- discuss administration frequencies
- list acceptable frequencies
- describe duration of methods
- define therapeutically effective amount
- discuss toxicity and therapeutic efficacy
- describe determination of therapeutic index
- discuss conversion of dosages
- introduce methods of inducing a response
- specify percentage of response
- introduce methods of treatment
- describe treatment of autoimmune diseases
- describe modulation of immune system
- describe treatment of allergic inflammation
- define terms related to treatment
- introduce vaccine formulations
- describe components of vaccine formulations
- discuss concentration of nanoparticles in vaccine formulations
- describe additional components of vaccine formulations
- define term "subject"

## EXAMPLES

### Reagents

- list reagents

### Synthesis of NPs

- synthesize TiO2 NPs
- synthesize CeO2 NPs

### Nanoparticle Characterization

- analyze NP shape, size, and morphology
- measure NP surface area
- determine NP size distribution
- confirm absence of contaminating LPS

### Human Donors and PBMC Isolation

- isolate PBMCs from healthy donors

### Generation of Cytokine-Derived DCs

- generate DCs from monocytes

### ROS Determination

- measure ROS levels in DCs

### DC Phenotyping

- stain DCs with antibodies
- analyze surface molecule expression

### Cellular Uptake

- measure NP uptake by DCs

### Luminex Cytokine Quantification Analysis

- collect supernatants from DC culture wells and DC:T cell co-cultures
- analyze cytokine production using Bioplex multiplexing array system
- isolate human CD4+ T cells from PBMC
- CFSE-label purified CD4+ T cells
- incubate CD4+ T cells with NPs with or without PHA/PMA
- co-culture T cells with DCs matured with TNFα and PGE2
- examine by flow cytometry using LIVE/DEAD AQUA, CD4+, CD25, Foxp3, and CFSE
- analyze data using FlowJo software
- perform Naïve CD4+ T Cell Allogeneic Stimulation Assay
- mature DCs with TNF-α and PGE2 or expose to NPs
- add DCs to allogeneic naïve CD4+ T cells labeled with CFSE
- use PHA/PMA as a positive control for T cell proliferation
- assess by flow cytometry using a BD Pharmingen LSR II
- collect supernatants and analyze for cytokines
- repeat each experiment with at least three donors
- determine statistical results using a paired Student's t-test
- set statistical significance at p<0.05
- produce graphs using GraphPad Prism software
- discuss nanoparticle cytotoxicity
- describe TiO2 and CeO2 NP applications
- investigate NP effects on DCs
- treat DCs with NPs and assess cell death and apoptosis
- analyze results using fluorescent apoptotic dye and vital dye
- discuss CeO2 NP non-cytotoxicity to human DCs
- examine phenotypic maturation of DCs
- treat DCs with TiO2 NPs and analyze surface costimulatory and MHC molecules
- investigate DC cytokine expression
- treat DCs with NPs and quantify cytokine levels in culture supernatants
- examine NP uptake by DCs using ICP-MS
- assess intracellular ROS levels in DC cultures
- analyze ROS levels using DCF-DA dye
- investigate NLRP3 inflammasome activation
- detect IL-1β secretion in TiO2 NP-treated DCs
- examine NP effects on CD4+ T cell proliferation and TH1/TH2 polarization
- co-administer NPs with PHA/PMA and analyze proliferative responses
- investigate NP effects on TReg induction and CD95 expression
- discuss adjuvant effects of TiO2 and CeO2 NPs

